News releases

Please be advised that the information posted was accurate at the time of posting, but may be superseded by subsequent news releases.

To automatically receive future news releases, please go to the News subscription service page.

[2015] - 2014 - 2013 - 2012 - 2011 - 2010 - 2009 - 2008 - 2007 - 2006 - 2005 - 2004 - 2003 - 2002

(click to view the full text)

April 27, 2015
Aeterna Zentaris: Data Safety Monitoring Board Recommends Continuation of Phase 3 Study of Zoptarelin Doxorubicin in Advanced Endometrial Cancer
April 23, 2015
Aeterna Zentaris to Present at 2015 Bloom Burton & Co. Healthcare Investor Conference in Toronto
April 16, 2015
Aeterna Zentaris Files Additional Patent Application to Strengthen IP Protection of Zoptarelin Doxorubicin
April 13, 2015
Aeterna Zentaris Announces Plans to Initiate Phase 3 Study of Macrilen™ in AGHD Following Successful Meeting with FDA
March 31, 2015
Aeterna Zentaris Signs Transfer Agreement of its Discovery Library with the Medical University of South Carolina
March 17, 2015
Aeterna Zentaris Reports Fourth Quarter and Full-Year 2014 Financial and Operating Results
March 11, 2015
Aeterna Zentaris Announces Closing of US$37 Million Public Offering of Common Shares and Warrants
March 10, 2015
Aeterna Zentaris to Announce Fourth Quarter and Full-Year 2014 Financial and Operating Results on March 17, 2015
March 6, 2015
Aeterna Zentaris Announces Pricing of US$37 Million Public Offering of Common Shares and Warrants
March 5, 2015
Aeterna Zentaris Announces Proposed Public Offering of Common Shares and Warrants
March 2, 2015
Aeterna Zentaris to Present at Roth Conference 2015
January 6, 2015
Aeterna Zentaris to Present at Upcoming Biotech Showcase Conference in San Francisco